Companies / Deals
Qiagen Agrees to EQT Takeover at €46.50 a Share, a €10.8 Billion Enterprise Value
The board-backed cash tender offer carries a 40.3% premium to the unaffected price and targets a mid-2027 close — and it arrived in the same announcement as a preliminary third quarter and a suspended outlook.